Study for registration of multi-center cases of cervical spondylosis (rheumatism and blood stasis syndrome) treated by Jingfukang Granule in the real world

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023298

Enrollment

Unknown

Registered

2019-05-21

Start date

2019-06-18

Completion date

Unknown

Last updated

2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical spondylosis

Interventions

experimental group:Cervical fukang granules

Eligibility

Sex/Gender

All

Age

16 Years to 87 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of western medicine for cervical spondylosis (nerve root type, vertebral artery type, sympathetic type, cervical type, myeloid type and mixed type); 2. Patients with traditional Chinese medicine diagnosis criteria of rheumatism and blood stasis can be selected. 3. Voluntarily sign the informed consent form and agree to participate in all visits as required by the research program.

Exclusion criteria

Exclusion criteria: 1. Those who are known to be allergic to the components of cervical fukang granules; 2. Pregnant or lactating women; 3. Cervical spondylotic myelopathy requires surgery; 4. Other circumstances that the researcher considers inappropriate for the study.

Design outcomes

Primary

Measure	Time frame
Visual analogue scale,VAS;	—

Countries

China

Contacts

Public ContactGe Jirong

Fujian Academy of Traditional Chinese Medicine

gjrrjgcy@163.com+86 13706957292

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026